Gossamer Bio, Inc.
GOSS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $205 | $206 | $184 | $846 |
| - Cash | $46 | $32 | $112 | $183 |
| + Debt | $203 | $212 | $226 | $185 |
| Enterprise Value | $361 | $386 | $297 | $848 |
| Revenue | $115 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $115 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| EBITDA | -$40 | -$162 | -$211 | -$209 |
| % Margin | -34.8% | – | – | – |
| Net Income | -$57 | -$180 | -$229 | -$234 |
| % Margin | -49.3% | – | – | – |
| EPS Diluted | -0.25 | -1.18 | -2.84 | -3.33 |
| % Growth | 78.8% | 58.5% | 14.7% | – |
| Operating Cash Flow | -$3 | -$159 | -$187 | -$189 |
| Capital Expenditures | $0 | $0 | -$0 | -$2 |
| Free Cash Flow | -$3 | -$159 | -$188 | -$191 |